Paid Clinical Trials Boca Raton
Discover 1,252 paid clinical trials in Boca Raton, Florida. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
LumateperoneMulticenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients
Sponsor:
Intra-Cellular Therapies, Inc.
Location:
Code:
NCT06372964
Conditions
Bipolar Depression
Eligibility Criteria
Sex: All
Age: 10 - 17
Healthy Volunteers: Not accepted
Interventions
Lumateperone
Placebo
Genetic RegistryParkinson's Foundation PD GENEration Genetic Registry
Sponsor:
Parkinson's Foundation
Location:
Code:
NCT04994015
Conditions
Parkinson's Disease
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Lab Assay for seven genetic variants for Parkinson's Disease
Dipraglurant with LevodopaDipraglurant (ADX48621) for the Treatment of Patients With Parkinson's Disease Receiving Levodopa-based Therapy
Sponsor:
Addex Pharma S.A.
Location:
Code:
NCT04857359
Conditions
Parkinson Disease
Dyskinesia, Drug-Induced
Dyskinesias
Eligibility Criteria
Sex: All
Age: 30 - 70+
Healthy Volunteers: Not accepted
Interventions
Dipraglurant
Placebo
CenerimodA Research Study to Evaluate the Effects of a New Oral Medicine Called Cenerimod in Adults With Systemic Lupus Erythematosus
Sponsor:
Idorsia Pharmaceuticals Ltd.
Location:
Code:
NCT05648500
Conditions
Lupus Erythematosus, Systemic
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
Cenerimod
Placebo
TEV-56286A Study to Test if TEV-56286 is Effective in Relieving Multiple System Atrophy (MSA): A Safety and Efficacy Study
Sponsor:
Teva Branded Pharmaceutical Products R&D, Inc.
Location:
Code:
NCT06568237
Conditions
Multiple System Atrophy
Eligibility Criteria
Sex: All
Age: 30+
Healthy Volunteers: Not accepted
Interventions
TEV-56286
Placebo
BTLA & Anti-PD1Safety, Tolerability and Pharmacokinetics of a Monoclonal Antibody Specific to B-and T-Lymphocyte Attenuator (BTLA) as Monotherapy and in Combination With an Anti-PD1 Monoclonal Antibody for Injection in Subjects With Advanced Malignancies
Sponsor:
TopAlliance Biosciences
Location:
Code:
NCT04137900
Conditions
Advanced Unresectable Solid Tumor
Metastatic Solid Tumor
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
TAB004
Toripalimab
PovorcitinibA Study to Evaluate the Efficacy and Safety Study of Povorcitinib in Participants With Prurigo Nodularis (STOP-PN1)
Sponsor:
Incyte Corporation
Location:
Code:
NCT06516952
Conditions
Prurigo Nodularis
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
Povorcitinib
Placebo
Efgartigimod IVA Phase 3 Study to Evaluate the Efficacy and Safety of Efgartigimod IV in Patients with Acetylcholine Receptor Binding Antibody Seronegative Generalized Myasthenia Gravis
Sponsor:
argenx
Location:
Code:
NCT06298552
Conditions
Generalized Myasthenia Gravis
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Efgartigimod IV
Placebo IV
CladribineEfficacy and Safety of a New Formulation of Oral Cladribine Compared With Placebo in Participants With Generalized Myasthenia Gravis (MyClad)
Sponsor:
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
Location:
Code:
NCT06463587
Conditions
Generalized Myasthenia Gravis
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Placebo
Cladribine Low Dose
Cladribine High Dose
TREOPost-Approval Study of the TREO Abdominal Stent-Graft System
Sponsor:
Bolton Medical
Location:
Code:
NCT04697784
Conditions
Abdominal Aortic Aneurysm
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
TREO Abdominal Stent-Graft System